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The Danish translation and validation of  
the Berlin Questionnaire for sleep apnoea
Elisabeth Lauritzen, Asbjørn Kørvel-Hanquist & Preben Homøe 
Obstructive sleep apnoea (OSA) is a common sleep-re-
lated breathing disorder with an estimated prevalence 
of up to 20% in adults [1-4]. Up to 82% of men and 
93% of women with moderate to severe OSA remain 
undiagnosed [5]. The prevalence of OSA varies by age, 
sex and Body-Mass Index (BMI), with a prevalence of 
49% with advanced age and up to 45% in obese indi-
viduals [6, 7]. 
OSA is associated with an increased risk of hyper-
tension, cardiovascular disease, low quality of life, met-
abolic syndrome, diabetes and all-cause mortality [4, 
8]. Risk factors are obesity, abnormalities in the upper 
respiratory airways, alcohol overuse and smoking [2, 
4]. Symptoms are daytime sleepiness, automobile or 
work-related accidents, personality change or cognitive 
difficulties [1]. 
The Apnoea/Hypopnoea Index (AHI) determines 
the presence or absence of OSA [2], which is divided 
into three groups; mild (AHI 5- <15), moderate (AHI 
≥ 15-30) and severe (AHI ≥ 30) [1, 2]. According to 
international guidelines, moderate to severe OSA (AHI 
≥ 15) is considered clinically relevant and requires 
treatment [9, 10]. The national threshold for treatment 
in Denmark is AHI ≥ 15 [11]. 
The gold standard for diagnosing OSA is polysom-
nography (PSG) [1, 4]. Cardiac respiratory monitoring 
(CRM) is often used as an equivalent gold standard be-
cause it does not require hospital admission and is 
more cost-effective [2, 12, 13]. 
The Berlin Questionnaire (BQ) was an outcome  
of the 1996 Conference On Sleep in Primary Care  
[14]. 
The BQ consists of ten questions divided into three 
categories [8]. Category 1 consists of an introductory 
question followed by four questions about snoring be-
haviour. A high risk is defined as persistent symptoms 
(>3-4 times/week) in two or more questions. Category 
2 contains two questions about daytime sleepiness, fol-
lowed by two questions on sleepiness when driving. 
Persistent (> 3-4 times/week) daytime sleepiness and/
or sleepiness while driving defines a high risk. Category 
3 concerns history of high blood pressure. A high risk is 
defined as history of high blood pressure or BMI > 30 
kg/m2 [14]. The patient is at high risk of OSA if the in-
dividual scores a positive/high risk on a least two of the 
three categories [8, 14]. 
This study aimed to translate and validate the Berlin 
Questionnaire on sleep apnoea into Danish and to test 
the questionnaire for screening of OSA in an adult 
Danish population. 
METHODS 
Translation 
The BQ was translated according to the 5-stage guide-
lines presented by Beaton et al [15].
Stage 1 - the original questionnaire was translated 
from English into Danish by two independent bilingual 
individuals. Stage 2 - the two translations were synthe-
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INTRODUCTION: Obstructive sleep apnoea (OSA) is an 
increasing health problem related to cardiovascular disease, 
poor quality of life, daytime sleepiness and un-restorative 
sleep with an estimated prevalence up to 20% in the adult 
population. Approximately 82% of men and 93% of women 
with moderate to severe OSA remain undiagnosed. Relevant, 
fast, accurate and cost-effective screening methods are 
essential.  
The aim of this study was to translate and validate the 
Danish version of the Berlin Questionnaire (BQ), and to 
investigate if the questionnaire can be used for screening of 
OSA in a Danish population.
METHODS: The BQ was translated into Danish according to 
guidelines producing the Danish Berlin Questionnaire (DBQ). 
The study population included 206 adult patients referred to 
the Sleep Clinic of Zealand University Hospital, Denmark, on 
suspicion of OSA.
RESULTS: 69.4% were males, 53.3% were obese (BMI > 30), 
the mean BMI was 32.01. A total of 135 patients had 
hypertension (65.5%). Apnoea/hypopnoea Index (AHI) ≥ 15 
was present in 141 of 206 patients (68.4%). We observed a 
sensitivity of the DBQ of 84% and a positive predictive value 
of 69%.
CONCLUSIONS: We have successfully translated and 
partially validated the DBQ for OSA. Our study showed that 
the DBQ is useful for screening of Danish patients suspected 
of OSA. Further studies with improved screening methods 
and further development of questionnaires are 
recommended.
FUNDING: none.
TRIAL REGISTRATION: The study was approved by the 
Danish Data Protection Agency..
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sised, producing one translation. Stage 3 - the question-
naire was translated back into English by two other in-
dependent bilingual individuals. Stage 4 - the original 
questionnaire and the translated version were com-
pared and subjected to a committee review, yielding a 
single Danish pre-version. Stage 5 - the Danish BQ 
(DBQ) was pretested on 20 patients who met the 
study’s inclusion criteria. The DBQ was then re-evalu-
ated for any linguistic misinterpretations, and the final 
DBQ was agreed upon (Figure 1). 
Validation 
The study population consisted of patients referred to 
the Sleep Clinic of Zealand University Hospital, Den-
mark, on suspicion of OSA from 1 December 2016 to 30 
April 2017. Inclusion criteria were: suspicion of OSA, 
no previous diagnosed OSA, completed overnight CRM 
and DBQ. Patients who were unable to read or under-
stand Danish were excluded. 
A total of 208 patients met the inclusion criteria, 
and 206 completed the DBQ and were enrolled in the 
study.
Statistics
Baseline characteristics (age, sex, height, weight, BMI 
and AHI score) were described as mean ± 1 standard 
deviation (SD) for proportions with 95% confidence in-
tervals (CI). BMI was calculated based on height and 
weight (kg/m2).
The risk of OSA determined by the DBQ was com-
pared with the AHI results. Statistical analyses were 
generated using SAS software (SAS Institute Inc. SAS 
Cary, North Carolina, USA). 
Patients were divided into two categories; »High 
OSA risk« if the DBQ score was ≥ 2 positive categories, 
and »Low OSA risk« if ≤ 1 positive category. 
Moderate to severe OSA (AHI ≥ 15) is considered 
clinically relevant and requires treatment; therefore, 
the cut-off score was AHI < 15 and AHI ≥ 15. 
The sensitivity, specificity and accuracy were calcu-
FIGURE 1
The translated Danish 
Berlin Questionnaire 
BERLIN SpøRgESkEMA 
Søvnapnø 
Højde (cm)  Vægt (kg)   
Alder (år)   Mand / Kvinde 
 
Sæt kryds ud for det rigtige svar til hvert spørgsmål 
 
kAtEgORI 1 
1. Snorker du? 
 a. Ja  
 b. Nej 
 c. Ved ikke 
 
Hvis du svarede ja: 
2. Din snorken er: 
 a. Lidt højere end din vejrtrækning 
 b. Så højt som tale 
 c. Højere end tale 
 
Hvor ofte snorker du? 
 a. Næsten hver dag 
 b. 3-4 gange om ugen 
 c. 1-2 gange om ugen 
 d. 1-2 gange om måneden 
 e. Sjældent eller aldrig 
Har din snorken generet andre? 
 a. Ja 
 b. Nej 
 c. Ved ikke 
 
Har andre observeret at du holder op med at trække vejret  
under søvn? 
 a. Næsten hver dag 
 b. 3-4 gange om ugen 
 c. 1-2 gange om ugen 
 d. 1-2 gange om måneden 
 e. Sjældent eller aldrig
kAtEgORI 2 
Hvor ofte føler du dig træt eller udmattet efter søvn? 
 a. Næsten hver dag 
 b. 3-4 gange om ugen 
 c. 1-2 gange om ugen 
 d. 1-2 gange om måneden 
 e. Sjældent eller aldrig 
I dine vågne timer, hvor ofte føler du dig træt, udmattet eller  
ikke på toppen? 
 a. Næsten hver dag 
 b. 3-4 gange om ugen 
 c. 1-2 gange om ugen 
 d. 1-2 gange om måneden 
 e. Sjældent eller aldrig 
Er du nogensinde faldet i søvn, eller været ved at falde i søvn,  
mens du kørte i bil? 
 a. Ja 
 b. Nej 
 
Hvis du svarede ja: 
Sker det ofte? 
 a. Næsten hver dag 
 b. 3-4 gange om ugen 
 c. 1-2 gange om ugen 
 d. 1-2 gange om måneden 
 e. Sjældent eller aldrig 
kAtEgORI 3 
Har du forhøjet blodtryk? 
 a. Ja 
 b. Nej 
 c. Ved ikke
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lated using 2 × 2 contingency tables. Positive predic-
tive value (PPV) and negative predictive value (NPV) 
were calculated to describe performance and accuracy. 
To assess the value of performing the DBQ, we calcu-
lated the positive likelihood ratio (LR+) and the nega-
tive likelihood ratio (LR-). Furthermore, the reliability 
and consistency of the DBQ were tested using 
Cronbach’s alpha (tau-equivalent reliability). 
Trial registration: The study was approved by the Dan-
ish Data Protection Agency. 
RESULTS 
The BQ was successfully translated into Danish, yield-
ing the final DBQ (Figure 1). 
In total, 206 patients completed the DBQ and under-
went overnight diagnostic CRM. The characteristics are 
given in Table 1. A total of 110 (53.3%) patients were 
obese (BMI > 30) and 135 had hypertension (65.5%). 
AHI ≥ 15 was present in 141 patients (68%), the to-
tal mean AHI of the population was 32.9. DBQ identi-
fied 173 of 206 (84%) as having a »high risk« of OSA 
and 33 (16%) as having a »low risk«. When screening 
for OSA with AHI ≥ 15 and »high risk« (DBQ ≥ 2 posi-
tive categories), the sensitivity was 0.84 (95% confi-
dence interval (CI) 0.78-0.90), and the specificity was 
0.17 (95% CI 0.08-0.26) (Table 2). 
Of 173 »high risk« patients, 119 had AHI ≥ 15, 
yielding a PPV of 0.69 (95% CI 0.61-0.75). The propor-
tion identified by the DBQ as having a »low risk« with 
AHI < 15 was 11 of 33, resulting in a NPV of 0.33 (95% 
CI 0.17-0.51). Fifty-four of 65 patients with an AHI < 
15 were identified as »high risk« patients, estimating a 
false positive probability of 0.83 (95% CI 0.73-0.92). 
Twenty-two of 141 had an AHI ≥ 15 and were classi-
fied as having a »low risk« of OSA, producing a false 
negative probability of 0.16 (95% CI 0.09-0.22). The 
accuracy of the DBQ to screen for OSA was 0.63 (95% 
CI 0.56-0.70) (Figure 2).
The LR+ for OSA with an AHI ≥ 15 was 1.02, and 
the LR- was 0.92. 
The internal consistency of categories one and two, 
calculated by Cronbach’s alpha coefficient, were 0.63 
and 0.67, respectively. Cronbach’s alpha coefficient for 
category three was irrelevant since it consists of a sin-
gle question. 
DISCUSSION
In this study, we have successfully translated the BQ ac-
cording to guidelines [15]. Our study was in line with 
previous studies examining the sensitivity, specificity, 
PPV and NPV.
The BQ has the highest number of validation stud-
ies, although the reported sensitivity and specificity 
varies [16-18]. 
There are other questionnaires, e.g., the STOP-
BANG questionnaire (SBQ) for detection of OSA that 
also show inconsistent sensitivity and specificity results 
[13, 16, 17, 19, 20]. 
We found an acceptable sensitivity of 0.84, which is 
consistent with previous studies where the sensitivity 
of the BQ ranged from 0.57 to 0.95 when tested in dif-
ferent populations [19, 17]. The rather high sensitivity 
of 0.84 in this study indicates that the DBQ is a reliable 
questionnaire for screening of patients suspected of 
OSA in a Danish population. We found the PPV to be 
0.69. Combined with a sensitivity of 0.84, this indicates 
that if the DBQ is positive, i.e., a »high risk of OSA«, 
there is a 69% likelihood that an individual actually has 
OSA.
TABLE 1
Males, n (%) 143 (69.4)
Age, mean ± 1 SD, yrs 52 ± 13.6
Height, mean ± 1 SD, m 1.76 ± 0.1
BMI, mean ±1 SD, kg/m2 32 ± 7.5
AHI, mean ± 1 SD  32.9 ± 27.5
AHI, n
[0-5] 13
[5-15] 52
[15-30] 53
≥ 30 88
Total 206
DBQ-score, n
High-risk: > 2 positive categories 173
Low-risk: < 1 positive category   33
Total 206
AHI = apnoea/hypopnoea index; DBQ = Danish Berlin Questionnaire;  
SD = standard deviation.
Baseline characteris-
tics of the study popu-
lation (N = 206).
TABLE 2
Contingency table: sensitivity, specificity, positive predictive value and negative predictive 
value of the Danish Berlin Questionnaire.
n
low risk high risk total Mean (95% CI)
AHI
< 15 11   54   65 –
≥ 15 22 119 141 –
Total 33 173 206 –
DBQ
Sensitivity – – – 0.84 (0.78-0.90)
Specificity – – – 0.17 (0.08-0.26)
Overall PPV – – – 0.69 (0.61-0.75)
Overall NPV – – – 0.33 (0.17-0.51)
AHI = apnoea/hypopnoea index; CI = confidence interval; DBQ = Danish Berlin Questionnaire; 
NPV = negative predictive value; PPV = positive predictive value.
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When comparing sensitivity, specificity, PPV and 
NPV of the BQ with those of the SBQ in studies on pa-
tients without history of sleep disorders, the results are 
very heterogeneous [16]. Abrishami et al [16] con-
ducted a systematic review on questionnaires for OSA 
comparing the SBQ and the BQ in a study population 
without a history of sleep disorders with an (AHI ≥ 
15). The SBQ had a sensitivity and a specificity of 0.93 
and 0.43, and the PPV and NPV were 0.51 and 0.90, re-
spectively. The BQ had a sensitivity in the 0.54–0.79 
range, a specificity in the 0.50–0.97 range, a PPV of 
0.50–0.97 and an NPV of 0.48–0.78. Bille et al trans-
lated and validated the SBQ in a Danish population of 
43 patients and found the sensitivity and specificity to 
be 1.0 and 0.59, respectively [13].
Kørvel-Hanquist et al validated the Danish SBQ in a 
Danish population comprising 208 patients and found 
a high sensitivity of 0.98 and a specificity of only 0.09, 
with a corresponding PPV and NPV of 0.53 and 0.82, 
respectively [20]. These studies indicate that the SBQ 
is more valid in screening for OSA than the BQ.
A systematic review and meta-analysis of the valid-
ity of the BQ by Senaratna et al [17] including 35 BQ 
studies reported a pooled sensitivity for clinically rele-
vant OSA (i.e. AHI ≥ 15) of 0.82, and a pooled specific-
ity of 0.35-0.39. The included studies on the SBQ re-
ported a higher sensitivity for clinically relevant OSA, 
but as for the BQ, most of these studies have not been 
conducted in the general population [17]. The variabil-
ity in the diagnostic utility between the BQ and SBQ is 
probably due in part to differences in type of sleep 
study and the definitions and cut-off values of AHI indi-
cating OSA. 
Research directly comparing these two question-
naires is needed to determine how best to use one or 
both in the screening for OSA. 
We found a low specificity of 0.17. Previous studies 
have reported the specificity of the BQ to fall in the 
0.32-0.95 range [16]. The low specificity can be ex-
plained by the study population, which consisted of pa-
tients referred on suspicion of OSA. The proportion of 
patients in this study with AHI < 15 was 31.5% (65 of 
206).
The false positive proportion of 0.83 indicates that 
many patients who do not suffer from OSA test as 
»high-risk« patients when subjected to the DBQ, and 
will therefore possibly be exposed to unnecessary test-
ing, evaluation and use of medical resources. A total of 
33 of the 206 patients tested as »low risk« according to 
the DBQ. Twenty-two of the 33 patients had an AHI ≥ 
15, resulting in a false negative proportion of 67%. 
When assessing the DBQ score, the clinical symp-
toms must also be considered. Therefore, if a patient 
with symptoms of OSA tests as »low risk«, further in-
vestigation with CRM is indicated. 
OSA is a disease with well-known serious conse-
quences. Therefore, the costs may seem to be of sec-
ondary importance when there are no risks associated 
with the diagnostic tests (CRM or PSG). In terms of 
OSA, rather than a high specificity, it is more important 
that a screening tool has a high sensitivity and does not 
miss patients with OSA. 
Our investigation found a PPV of 0.69 indicating 
that if DBQ is positive, i.e., a »high risk of OSA«, there is 
a 69% likelihood that an individual actually has OSA. 
This shows that the DBQ can be an important screening 
tool for patients suspected of OSA. 
The internal consistencies calculated by Cronbach’s 
alpha coefficient were 0.63 and 0.67 for category one 
and two, respectively, indicating that snoring behav-
iour, daytime sleepiness/fatigue and drowsiness while 
driving are reliable elements in the measurement of 
OSA.
Our study shows that the DBQ has a high sensitivity 
for detection of clinically relevant OSA (AHI ≥ 15) in 
patients suspected of having OSA. The DBQ is simple 
and easy to understand, it can be done in a primary 
care setting and is inexpensive. The use of the DBQ 
could potentially identify many patients suffering from 
OSA, leading to their correct and quick diagnosis and 
treatment. 
Limitations
Six of the included 206 patients (3%) did not have a 
driver’s license/had never driven a motor vehicle, thus 
scoring zero points in questions about drowsiness while 
FIGURE 2
Box-plot correlation between Apnoea/hypopnoea Index (AHI) ≥ 15 
and Danish Berlin Questionnaire (DBQ) score: low-risk (i.e. ≤ 1) and 
high-risk (i.e. ≥ 2) score. 
150
125
100
50
25
0
75
Low risk High risk
Outer lines: min./max. AHI-score. Blue-box: 25/75 percentile. Midlines: median/50 
percentile. Small square: mean.
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driving. However, this did not change the internal con-
sistency of the DBQ. 
The expert committee revising the translation of the 
DBQ in stage four of the translation process and the 
pre-test results in stage five did not find test-retest cru-
cial to the structure and contents of the questionnaire. 
The Danish translation of the questionnaire was found 
to be unambiguous. Test-retest is recommended in fur-
ther studies to assess the reproducibility of the DBQ. 
CONCLUSIONS
We have translated and partially validated the Danish 
version of the DBQ for sleep apnoea. Our study shows 
that the DBQ is useful for screening of Danish patients 
suspected of OSA, but not for those without OSA. Fur-
ther studies conducted in the general population are 
needed. 
The results of the DBQ are comparable to other 
studies, but improved screening methods and further 
development is needed. The potential effect of com-
bined use of available questionnaires would be interest-
ing to examine. 
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CORRECTIONS:
IN THE ARTICLE: ”The Danish translation and validation of the Berlin 
Questionnaire for sleep apnoea” The following corrections has been made 
at 21th September 2018.
A NEw VERSION OF TABLE 2 HAS BEEN ADDED.
IN FIGURE 2 THE FIGURE TExT HAS BEEN EDITED FROM “BOx-PLOT 
CORRELATION BETwEEN AHI ≥ 15 AND DBQ-SCORE: low-risk and high-
risk” to: “Box-plot correlation between Apnoea/hypopnoea Index (AHI) ≥ 15 
and Danish Berlin Questionnaire (DBQ) score: low-risk (i.e. ≤ 1) and high-
risk (i.e. ≥ 2) score.” 
THE FOLLOwING PARAGRAPH HAS BEEN DELETED FROM THE PARA-
GRAPH “LIMITATIONS” AND ADDED TO THE PARAGRAPH “DISCUSSION”: 
“Our study shows that the DBQ has a high sensitivity for detection of clini-
cally relevant OSA (AHI ≥ 15) in patients suspected of having OSA. The DBQ 
is simple and easy to understand, it can be done in a primary care setting 
and is inexpensive. The use of the DBQ could potentially identify many 
patients suffering from OSA, leading to their correct and quick diagnosis 
and treatment.”
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